Case Report: iMDT Corner
Ripretinib for the treatment of metastatic gastrointestinal stromal tumors harboring dual mutations in KIT exons 11+17: a case report
Gastrointestinal Stromal Tumor
2024;
7:
2
(30 December 2024)